Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

September 2016 Issue of The Pathologist

“Welcome to our September issue. This month, our Upfront articles tackle testing for Lynch syndrome and lipid disorders and look at a new technique for rapidly identifying pathogens. In My View contains pathology residents’ recommendations for improving medical school curricula before it’s too late. Our Feature is a gallery showcasing images from all fields of laboratory medicine, created and submitted by the experts – you. In Practice discusses the Blueprint Project aiming to compare and characterize PD-L1 assays and the practical implementation of long-distance diagnostics. NextGen includes blood biomarkers for asthma and software to diagnose infectious diseases, whereas Profession calls for better regulation of diagnostic tests. We Sit Down With Ivan Damjanov, pathologist and expert educator at the University of Kansas School of Medicine.”

Register to download

Register here to download any issue of The Pathologist for FREE.

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

Articles featured in this issue

Inside the Lab Profession

Humble Versus Harmful

| Fedra Pavlou

Lab medicine saves lives every day in humanitarian crises – why does nobody talk about it?

Outside the Lab Oncology

Reflex Recommendations

| Michael Schubert

RCPath and Bowel Cancer UK call for improved Lynch syndrome testing in young patients

Inside the Lab Biochemistry and molecular biology

A New Angle on CKD

| Michael Schubert

D-amino acid levels may reveal which CKD patients are at greatest risk of progression

Outside the Lab Screening and monitoring

To Screen or Not to Screen?

| Michael Schubert

Are the benefits of childhood lipid disorder screening worth the costs and risks?

Diagnostics Oncology

How the Bullet Lost its Magic

| Michael Schubert

Changes in P-glycoprotein expression could explain leukemia patients' treatment resistance

Outside the Lab Microscopy and imaging

Waging War on Resistance

| Michael Schubert

Automated digital microscopy reduces time to diagnose multidrug-resistant infections

Inside the Lab Profession

The Pathologist’s 2016 Power List

The Pathologist’s 2016 “Rising Stars” Power List nominations are now open!

Inside the Lab Training and education

Undermined and Undervalued

| H. Cliff Sullivan

Practical ideas for changing medical school curricula before it’s too late for pathology.

Inside the Lab Microscopy and imaging

Through the Looking Glass

| Michael Schubert

The beautiful world of pathology seen through a gallery of laboratory medicine images.

Inside the Lab Digital and computational pathology

Through the Looking Glass Continued

| Michael Schubert

The beautiful world of pathology seen through a gallery of laboratory medicine images.

Outside the Lab Quality assurance and quality control

A Blueprint for the Future

| Henrik Winther and Hans Christian Pedersen

Industry and regulators collaborate to harmonize or consolidate PD-1/PDL-1 assays

Outside the Lab Profession

Diagnostics at a Distance

| Sebastian Brandner

How one neuropathology institute provides full diagnostic services to a remote hospital

Diagnostics Genetics and epigenetics

From Blood to Breath

| Faoud Ishmael

Circulating miRNAs may serve as noninvasive biomarkers for respiratory disorders

Diagnostics Technology and innovation

Diagnosis Ex Machina

| Robert Schlaberg

A new software tool may return faster, more accurate infectious disease diagnoses

Outside the Lab Profession

Quis Custodiet?

| Patrick Bossuyt

Diagnostic tests are not evaluated as rigorously as pharmaceuticals, but this must change

Outside the Lab Training and education

The Changing Man

| Fedra Pavlou

Ivan Damjanov, Professor of Pathology, University of Kansas School of Medicine, Kansas City, USA

Outside the Lab Screening and monitoring

Micro Sample, Maximum Outcome

Next-generation microsampling overcomes limitations of traditional DBS and wet sampling.

Other issues of 2016